Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Hoffman

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Nuclear Medicine and Biology|October 3, 2019
Improved production of <sup>76</sup>Br, <sup>77</sup>Br and <sup>80m</sup>Br via CoSe cyclotron targets and vertical dry distillationPaul A Ellison, Aeli P Olson, Todd E Barnhart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Nuclear Medicine and Biology|October 3, 2019
Improved production of <sup>76</sup>Br, <sup>77</sup>Br and <sup>80m</sup>Br via CoSe cyclotron targets and vertical dry distillationPaul A Ellison, Aeli P Olson, Todd E Barnhart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
Pageof 5